← Back to Search

Vitamin D

Vitamin D for Chronic Pain After Burns

Phase 2
Recruiting
Led By Matthew Mauck, MD, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients experience a thermal burn injury, not an electrical or chemical burn.
Burn survivors with acute pain severity ≥ 7/10 on the Numeric Rating Scale (initial pain severity reported by the patient on screening)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 week, 2 week, 3 week, 4 week, 5 week, and 6 weeks, 3 months, 6 months
Awards & highlights

Study Summary

This trial will study if Vitamin D can reduce chronic pain after burn injury, and examine its effects on the immune system. Participants will take pills, provide blood samples and answer surveys.

Who is the study for?
Adults aged 18-70 with thermal burns covering less than 30% of their body, experiencing significant pain (≥7/10), and admitted for surgical burn wound management. Participants must be alert, speak English, willing to take study medication, have a smartphone, and not have severe kidney disease or certain other health conditions.Check my eligibility
What is being tested?
This trial is testing if Vitamin D can prevent chronic pain after a burn injury by comparing the effects of Vitamin D capsules to placebo. It will also explore how Vitamin D affects immune system changes post-injury through blood samples and surveys up to six months.See study design
What are the potential side effects?
Potential side effects may include high calcium levels in the blood which could cause weakness, confusion, or digestive issues. However, since it's a vitamin supplement at controlled doses, serious side effects are considered unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My burn injury is caused by heat, not electricity or chemicals.
Select...
I am a burn survivor with pain level of 7 or more out of 10.
Select...
I am between 18 and 70 years old.
Select...
I am currently admitted to a burn center.
Select...
I am willing to take 6 capsules daily for the study.
Select...
Less than 30% of my body is burned.
Select...
Less than 30% of my body is burned.
Select...
I have a burn injury caused by heat, not by electricity or chemicals.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 week, 2 week, 3 week, 4 week, 5 week, and 6 weeks, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 week, 2 week, 3 week, 4 week, 5 week, and 6 weeks, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Burn injury
Secondary outcome measures
25-hydroxyvitamin D concentration 6 weeks after Vitamin D2 treatment
By Group Efficacy Estimates Over Year Following Thermal Burn Injury
Neuralgia
+5 more
Other outcome measures
Inflammatory immune cells populations assessed with mass cytometry

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Vitamin D2 (Ergocalciferol)Active Control1 Intervention
One time, oral dose of Vitamin D2 administered via 6 50,000 IU Ergocalciferol capsules. Capsules will be encapsulated and masked to be indistinguishable from placebo.
Group II: PlaceboPlacebo Group1 Intervention
One time, oral dose of 6 placebo capsules filled with inert powder and encapsulated and masked to be indistinguishable from active comparator.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,191,002 Total Patients Enrolled
7 Trials studying Burns
629 Patients Enrolled for Burns
National Center for Complementary and Integrative Health (NCCIH)NIH
832 Previous Clinical Trials
668,933 Total Patients Enrolled
Matthew Mauck, MD, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

Ergocalciferol (Vitamin D) Clinical Trial Eligibility Overview. Trial Name: NCT05619289 — Phase 2
Burns Research Study Groups: Vitamin D2 (Ergocalciferol), Placebo
Burns Clinical Trial 2023: Ergocalciferol Highlights & Side Effects. Trial Name: NCT05619289 — Phase 2
Ergocalciferol (Vitamin D) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05619289 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How do I sign-up for this chance to participate in this research?

"The inclusion criteria for this trial requires that patients have suffered a burn injury and are between 18-65 years old. So far, 40 people have been recruited into the study."

Answered by AI

Are researchers actively looking for new participants for this trial?

"According to the latest update on clinicaltrials.gov, this trial is not currently looking for patients. This study was first posted on November 1st, 2022 and was last edited less than a week ago on the 8th. There are 499 other trials that are open for enrollment at this time."

Answered by AI

What is the FDA's opinion on Vitamin D2 for public consumption?

"There is limited data to support the efficacy of Vitamin D2 (Ergocalciferol), but it has received a score of 2 due to the clinical evidence affirming its safety."

Answered by AI

Does this research project allow people who are over 35 years old to participate?

"The age range that this clinical trial is willing to accept patients is those who are 18 years old or above, and 65 years old or below."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
What site did they apply to?
University Of North Carolina
What portion of applicants met pre-screening criteria?
Did not meet criteria
~6 spots leftby Jul 2024